Effect of novel atypical antipsychotic, blonanserin, on extracellular neurotransmitter level in rat prefrontal cortex

European Journal of Pharmacology
Keiko OhoyamaMotohiro Okada


To clarify the mechanisms of action of blonanserin, an atypical antipsychotic drug, we studied the effects of systemic administration of blonanserin and risperidone on extracellular levels of norepinephrine, dopamine, serotonin, GABA and glutamate in the medial prefrontal cortex using microdialysis, and neuronal firing in the ventral tegmental area, locus coeruleus, dorsal raphe nucleus and mediodorsal thalamic nucleus using radiotelemetry. The binding affinities of blonanserin to D(2) and 5-HT(2A) receptors in the rat brain were confirmed and found to be similar. Blonanserin transiently increased neuronal firing in locus coeruleus and ventral tegmental area but not in dorsal raphe nucleus or mediodorsal thalamic nucleus, whereas risperidone increased the firing in locus coeruleus, ventral tegmental area and dorsal raphe nucleus but not in mediodorsal thalamic nucleus. Blonanserin persistently increased frontal extracellular levels of norepinephrine and dopamine but not serotonin, GABA or glutamate, whereas risperidone persistently increased those of norepinephrine, dopamine and serotonin but not GABA or glutamate. These results suggest a pharmacological correlation between the stimulatory effects of these antipsychotics on fro...Continue Reading


Jan 1, 1983·Brain Research Bulletin·T A Reader, R Brière
Jul 1, 1997·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·P HertelT H Svensson
Jan 16, 1998·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·J Arnt, T Skarsfeldt
Sep 2, 1998·Progress in Neuro-psychopharmacology & Biological Psychiatry·P HertelT H Svensson
Feb 9, 2000·Psychopharmacology·H Y Meltzer
Feb 24, 2000·Naunyn-Schmiedeberg's Archives of Pharmacology·H L RowleyD J Heal
May 2, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·G L GessaM Pistis
Aug 16, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·W ZhangFrank P Bymaster
Feb 28, 2003·The Journal of Pharmacology and Experimental Therapeutics·Shitij KapurJose N Nobrega
Dec 4, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Herbert Y MeltzerJunji Ichikawa
Oct 20, 2004·The Journal of Cell Biology·Fubito NakatsuHiroshi Ohno
Dec 14, 2004·European Journal of Pharmacology·Taco R WerkmanWytse J Wadman
Dec 3, 2005·European Journal of Pharmacology·Shigeo NakamuraToshio Matsuda
Mar 16, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Xavier López-GilAlbert Adell
Mar 31, 2007·Journal of Neurochemistry·Mercè Amargós-BoschFrancesc Artigas
Nov 21, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Gang ZhuShinichi Hirose
Jul 4, 2009·Psychopharmacology·Satoshi YamamuraMotohiro Okada
Dec 25, 2009·CNS Drugs·Emma D Deeks, Gillian M Keating
Feb 20, 2010·Current Topics in Medicinal Chemistry·Gérard Rossé, Hervé Schaffhauser
May 13, 2010·Pharmacology, Biochemistry, and Behavior·Yukihiro OhnoSaki Shimizu


Sep 13, 2012·European Archives of Psychiatry and Clinical Neuroscience·Nina PeselmannMathias Zink
Jun 15, 2013·Neuropsychiatric Disease and Treatment·Tomomi TenjinNoboru Yamaguchi
Sep 13, 2014·European Archives of Psychiatry and Clinical Neuroscience·Mathias ZinkAndrea Schmitt
Jan 27, 2012·Human Psychopharmacology·Tomomi TenjinNoboru Yamaguchi
May 20, 2014·Psychiatry and Clinical Neurosciences·Yuriko NinomiyaNoboru Yamaguchi
Apr 4, 2015·Journal of Pharmacological Sciences·Satoko BabaMichiko Ono
Aug 1, 2014·Behavioural Brain Research·Davide Amato
Feb 17, 2018·Pharmaceutical Research·Willem Johan van den BrinkElizabeth Cunera Maria de Lange
Nov 11, 2011·Journal of Psychiatric and Mental Health Nursing·M A Aldridge

Related Concepts

Norepinephrine, (+, -)-Isomer
Plasma Protein Binding Capacity
Antipsychotic Effect
Rats, Holtzman

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here